Monopar Therapeutics Q4 EPS $(0.61) Misses $(0.54) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings MissesNews
Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.54) by 12.96 percent. This is a 72.65 percent increase over losses of $(2.23) per share
Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.54) by 12.96 percent. This is a 72.65 percent increase over losses of $(2.23) per share from the same period last year.